Ledger.Open graph →
SEC Form D · filed January 26, 2023

ADARx Pharmaceuticals, Inc

Offering
$46.0M
Sold
$46.0M
Exemption
Rule 506(b)
Industry
Pharmaceuticals
Location
SAN DIEGO, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (20)

Zhen Li · San Diego, CAExec · DirectorRui Zhu · San Diego, CAExecCarl Gordon · SAN FRANCISCO, CADirectorWilliam P. Connor · Houston, TXExec · DirectorSheila Gujrathi · San Diego, CADirectorLorence Kim · Cambridge, MADirectorJudith Li · Danvers, MADirectorErez Chimovits · Tel Aviv, L3DirectorSimeon George · Cambridge, MADirectorYuan (Eliza) Sun · San Diego, CADirectorCarl Gordon · Encinitas, CADirectorRuss Ivinjack · Chicago, ILExec · DirectorSheila Gujrathi · La Jolla, CADirectorLorence Kim · Cambridge, MADirectorJudith Li · Danvers, MADirectorErez Chimovits · Herzeliya, L3DirectorSimeon George · Menlo Park, CADirectorRui Zhu · San Diego, CAExecYuan (Eliza) Sun · San Diego, CADirectorCarl Gordon · CAMBRIDGE, MADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗